Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,404 across all filing types
Latest filing 2026-05-01 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Regulatory Filings
2026-05-01 English
Total Voting Rights and Admission of Shares
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a notification made under the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1 regarding total voting rights as of 30 April 2026. It also includes details about the admission of further securities to trading under the Public Offers and Admissions to Trading Regulations 2024. The content focuses on share capital, voting rights, and admission of shares under employee share schemes. There are no financial statements, management discussion, or earnings data. The document is an official announcement about voting rights and share admission, fitting the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4440 characters, which is consistent with an announcement rather than a full report.
2026-05-01 English
Total Voting Rights and Admission of Shares
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a regulatory news release from AstraZeneca dated 1 May 2026. It provides details on the total voting rights as of 30 April 2026 and notification of admission of further securities to trading on the London Stock Exchange. The content focuses on share capital, voting rights, and admission of shares under employee share schemes. It references compliance with UK Financial Conduct Authority rules and Public Offers and Admissions to Trading Regulations. The document is short (3155 characters) and serves as an official announcement regarding voting rights and share admission, not a full financial report or detailed analysis. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-01 English
FDA ODAC VOTE ON CAMIZESTRANT IN BREAST CANCER
Regulatory Filings
2026-05-01 English
FDA ODAC RECOMMENDS TRUQAP IN PROSTATE CANCER
Regulatory Filings
2026-05-01 English
FDA ODAC vote on camizestrant in breast cancer
Regulatory Filings Classification · 95% confidence The document is an update from AstraZeneca regarding the FDA Advisory Committee vote on a drug (camizestrant) for breast cancer treatment. It discusses clinical trial results, regulatory review status, and scientific data related to the drug's efficacy and safety. The document is an announcement of regulatory and clinical development progress rather than a full financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. It is a regulatory announcement providing information on a regulatory review and clinical trial outcome, fitting best into the category of Regulatory Filings (RNS). The document length is substantial but the content is focused on regulatory and clinical update rather than a formal report or filing like an Annual Report or Earnings Release.
2026-05-01 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.